Tools for healing non union fractures and primary lumbar spinal fusion procedures, A consultative approach to customized DME solutions. High-end products that improve quality of life and restore movement. DJO, a subsidiary of Colfax Corporation (NYSE: CFX),is a leading developer and distributor of high-quality medical devices that provide proven solutions for musculoskeletal health, joint reconstruction, vascular health, and pain management. Colfax Corporation Trilliants market-leading portfolio of foot and ankle solutions complements our acquisition of the STAR system and creates a dedicated foot and ankle business that significantly expands our mission of Powering Motion, said Brady Shirley, CEO of DJO. Navigated start up acquisition (MedShape Inc.) by Fortune 500 company (Colfax / DJO Global) and following divestiture of businesses (ESAB) and subsequent integration (Enovis / Trilliant Surgical . In addition to having a broad product portfolio that covers the full universe of foot recon/fixation procedures, Trilliant Surgical is the only provider of the novel Arsenal Foot Plating System. Private Securities Litigation Reform Act of 1995. The contents of this website do not constitute medical, legal, or any other type of professional advice. Colfax Corporation Ankle replacement surgeries have grown over the last decade, and according to Musculoskeletal Clinical Regulatory Advisors, as of February 2011 all public insurance programs, workers compensation and 92% of commercial insured patients have access to ankle replacement procedures when deemed medically necessary by a trained surgeon. Innovative implant technologies that cover a wide range of solutions. The Companys extensive range of products and integrated technologies address the orthopedic continuum of care from performance and mobility to surgical intervention and post-operative rehabilitation; enabling people around the world to regain or maintain their natural motion. Manage Preferences. In addition, these statements are based on assumptions that are subject to change. 302.252.9129, To read the original press release, please click here, Copyright 2022 Catalyst Group | Powered by Omaha Media Group, Acquisition furthers expansion into growing foot and ankle surgery market. 1. Dallas, TX (January 19, 2021) - DJO, LLC (DJO or the Company), a leading global provider of medical technologies to get and keep people moving, today announced the acquisition of Trilliant Surgical, a national provider of foot and ankle orthopedic implants. Trilliant Surgical - acquired by DJO Medical Equipment Manufacturing Houston, TX 5,229 followers Follow View all 39 employees About us Trilliant Surgical creates and manufactures innovative,. Rehabilitation, pain management and healing. To learn more about what we collect and how we use that information, or to change your privacy settings see our Privacy Policy. DJOs unparalleled commitment to new product development, their iconic brands and strong growth trajectory will accelerate Trilliants ability to grow, innovate and improve patient outcomes., Ankle replacement surgeries have grown over the last decade, and according to Musculoskeletal Clinical Regulatory Advisors, as of February 2011 all public insurance programs, workers compensation and 92% of commercial insured patients have access to ankle replacement procedures when deemed medically necessary by a trained surgeon.1, For more information, visit djoglobal.com/TrilliantSurgical. The worldwide leading provider of diabetic footwear. DJO disclaims any duty to update the information herein. Published on January 20, 2021. DALLAS-- ( BUSINESS WIRE )-- DJO Global, LLC (DJO or the Company), a leading global provider of medical technologies to get and keep people moving, today announced the acquisition of Trilliant Surgical, a national provider of foot and ankle orthopedic implants. 760.681.7785, Internet Explorer presents a security risk. Trilliants market-leading portfolio of foot and ankle solutions complements our acquisition of the STAR system and creates a dedicated foot and ankle business that significantly expands our mission of Powering Motion, said Brady Shirley, CEO of DJO. Acquisition furthers expansion into growing foot and ankle surgery market DALLAS--(BUSINESS WIRE)--DJO, LLC (DJO or the Company), a leading global provider of medical technologies to get and keep people moving, today announced the acquisition of Trilliant Surgical, a national provider of foot and ankle orthopedic implants. The deal supports DJO's focus on expanding in the foot and ankle market, the release said. Manage Preferences. DJO, LLC (DJO or the Company), a leading global provider of medical technologies to get and keep people moving, today announced the acquisition of Trilliant Surgical, a national provider of foot and ankle orthopedic implants. The largest medical products acquisition in 2021 was Medline Industries - which was acquired by Hellman & Friedman for $34.0B. Orthopedic thoughts shared by your favorite Recruiter Tiger Buford, DJO Acquires Trilliant Surgical (press release). We are committed to building our Reconstructive segment and believe that the foot and ankle space is a great fit for our focused innovation and solutions approach that has allowed DJO to be a growth leader in the upper extremity market for many years.. CFX Colfax Corporation DJO Acquires Trilliant Surgical. For additional information about DJO, please visitwww.DJOGlobal.com. With unique features designed for greater flexibility and speed of implant placement supporting ease of use, less waste and reduced OR time, Arsenal is poised to be a plating leader. We also use cookies to target our marketing to your needs. As a foot and ankle champion since 2007, we are excited to join the DJO family and expand Trilliant Surgicals positive patient impact globally, said Jon Olson, CEO of Trilliant Surgical. investorrelations@colfaxcorp.com This press release may contain forward-looking statements, including forward-looking statements within the meaning of the U.S. Acquisition furthers expansion into growing foot and ankle surgery market, https://app.smarttrak.com/markets/qs/fd52946dc2bd8b02ac1002535b62cf35. The acquisition of Trilliant Surgicals leading product technologies and clinical efficacy supports DJOs focused expansion into the adjacent high-growth $1 billion US foot and ankle market. DJOs expansion into foot and ankle surgery complements its strong position in Total Ankle Replacements; in 2020, DJO acquired the Scandinavian Total Ankle Replacement (STAR) System, which holds a leading position in the global ankle arthroplasty market. Brittany.knudson[at]djoglobal[dot]com To learn more about what we collect and how we use that information, or to change your privacy settings see our Privacy Policy. DJO, a subsidiary of Colfax Corporation (NYSE: CFX), is a leading developer and distributor of high-quality medical devices that provide proven solutions for musculoskeletal health, joint reconstruction, vascular health, and pain management. To ensure the most secure and best overall experience on our website, we recommend the latest versions of, https://app.smarttrak.com/markets/qs/fd52946dc2bd8b02ac1002535b62cf35. The acquisition of Trilliant Surgicals leading product technologies and clinical efficacy supports DJOs focused expansion into the adjacent high-growth $1 billion US foot and ankle market. Individual results may vary. Acquisition furthers expansion into growing foot and ankle surgery market DJO, LLC (DJO or the Company), a leading global provider of medical technologies to get and keep people moving, today announ. Among the factors driving the high-growth foot and ankle market are a rapidly growing elderly population, sports-related injuries, and the increasing prevalence of diabetes and related lower-extremity conditions. In addition to having a broad product portfolio that covers the full universe of foot recon/fixation procedures, Trilliant Surgical is the only provider of the novel Arsenal Foot Plating System. Press DJO Acquires Trilliant Surgical Dallas, TX (January 19, 2021) - DJO, LLC (DJO or the Company), a leading global provider of medical technologies to get and keep people moving, today announced the acquisition of Trilliant Surgical, a national provider of foot and ankle orthopedic implants. The Companys extensive range of products and integrated technologies address the orthopedic continuum of care from performance and mobility to surgical intervention and post-operative rehabilitation; enabling people around the world to regain or maintain their natural motion. Forward-looking statements are based on DJOs current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements. DJOs unparalleled commitment to new product development, their iconic brands and strong growth trajectory will accelerate Trilliants ability to grow, innovate and improve patient outcomes., Restart Capital for Experienced Management Teams, https://app.smarttrak.com/markets/qs/fd52946dc2bd8b02ac1002535b62cf35, The right way to capitalize your business, Sanara MedTech Inc. DJO disclaims any duty to update the information herein. With unique features designed for greater flexibility and speed of implant placement supporting ease of use, less waste and reduced OR time, Arsenal is poised to be a plating leader. Ankle replacement surgeries have grown over the last decade, and according to Musculoskeletal Clinical Regulatory Advisors, as of February 2011 all public insurance programs, workers compensation and 92% of commercial insured patients have access to ankle replacement procedures when deemed medically necessary by a trained surgeon.1, For more information, visitdjoglobal.com/TrilliantSurgical. Brittany.knudson@djoglobal.com DJO, a subsidiary of Colfax Corporation (NYSE: CFX),is a leading developer and distributor of high-quality medical devices that provide proven solutions for musculoskeletal health, joint reconstruction, vascular health, and pain management. In addition to having a broad product portfolio that covers the full universe of foot recon/fixation procedures, Trilliant Surgical is the only provider of the novel Arsenal Foot Plating System. 760.681.7785, Mike Macek This press release speaks only as of the date hereof. Forward-looking statements are based on DJOs current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements. Neither DJO, LLC nor any of the Enovis companies dispense medical advice. Login. DALLAS -- (BUSINESS WIRE)-- DJO, LLC (DJO or the Company), a leading global provider of medical technologies to get and keep people moving, today announced the acquisition of Trilliant. The acquisition of Trilliant Surgical's product technologies and clinical efficacy will help DJO to focus more on expanding into the $1bn US foot and ankle market. Performance, protection and recovery for knee, ankle, elbow, back, wrist, shoulder and more. DALLAS--(BUSINESS WIRE)--DJO, LLC (DJO or the Company), a leading global provider of medical technologies to get and keep people moving, today announced the acquisition of Trilliant Surgical, a national provider of foot and ankle orthopedic implants. Factors that could cause DJOs results to differ materially from current expectations include, but are not limited to, risks related to the impact of the COVID-19 global pandemic, including actions by governments, businesses and individuals in response to the situation, such as the scope and duration of the outbreak, the nature and effectiveness of government actions and restrictive measures implemented in response, material delays and cancellations of medical procedures, supply chain disruptions, the impact on creditworthiness and financial viability of customers, and other impacts on DJOs business and ability to execute business continuity plans, and the other factors detailed in Colfaxs reports filed with the U.S. Securities and Exchange Commission (SEC), including its most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q under the caption Risk Factors, as well as the other risks discussed in Colfaxs filings with the SEC. Factors that could cause DJOs results to differ materially from current expectations include, but are not limited to, risks related to the impact of the COVID-19 global pandemic, including actions by governments, businesses and individuals in response to the situation, such as the scope and duration of the outbreak, the nature and effectiveness of government actions and restrictive measures implemented in response, material delays and cancellations of medical procedures, supply chain disruptions, the impact on creditworthiness and financial viability of customers, and other impacts on DJOs business and ability to execute business continuity plans, and the other factors detailed in Colfaxs reports filed with the U.S. Securities and Exchange Commission (SEC), including its most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q under the caption Risk Factors, as well as the other risks discussed in Colfaxs filings with the SEC. Dallas-based Colfax (NYSE: CFX) unit DJO's acquisition is meant to. As a foot and ankle champion since 2007, we are excited to join the DJO family and expand Trilliant Surgicals positive patient impact globally. Factors that could cause DJOs results to differ materially from current expectations include, but are not limited to, risks related to the impact of the COVID-19 global pandemic, including actions by governments, businesses and individuals in response to the situation, such as the scope and duration of the outbreak, the nature and effectiveness of government actions and restrictive measures implemented in response, material delays and cancellations of medical procedures, supply chain disruptions, the impact on creditworthiness and financial viability of customers, and other impacts on DJOs business and ability to execute business continuity plans, and the other factors detailed in Colfaxs reports filed with the U.S. Securities and Exchange Commission (SEC), including its most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q under the caption Risk Factors, as well as the other risks discussed in Colfaxs filings with the SEC. 760.681.7785, Mike Macek This press release may contain forward-looking statements, including forward-looking statements within the meaning of the U.S. investorrelations[at]colfaxcorp[dot]com Rather, please consult your healthcare professional for information on the courses of treatment, if any, which may be appropriate for you. Djo, LLC, a Lewisville, TX-based global provider of medical technologies to get and keep people moving, acquired Trilliant Surgical, a national provider of foot and . The worldwide leading provider of diabetic footwear. Trilliant Surgical was acquired by DJO Global on January 19, 2021. This press release speaks only as of the date hereof. The Arsenal system addresses a number of mid- and hind-foot procedures and will be extended to ankle, with the potential to achieve significant additional penetration of medical procedures. We are committed to building our Reconstructive segment and believe that the foot and ankle space is a great fit for our focused innovation and solutions approach that has allowed DJO to be a growth leader in the upper extremity market for many years.. Brittany Knudson Out of 60 sectors in the Mergr database, medical products ranked 13 in number of deals in 2021. The contents of this website do not constitute medical, legal, or any other type of professional advice. CAUTIONARY NOTE CONCERNING FORWARD LOOKING STATEMENTS. DJO Acquires Trilliant Surgical. Ankle replacement surgeries have grown over the last decade, and according to Musculoskeletal Clinical Regulatory Advisors, as of February 2011 all public insurance programs, workers compensation and 92% of commercial insured patients have access to ankle replacement procedures when deemed medically necessary by a trained surgeon. DJO, a subsidiary of Colfax Corporation (NYSE: CFX), is a leading developer and distributor of high-quality medical devices that provide proven solutions for musculoskeletal health, joint reconstruction, vascular health, and pain management. In addition to having a broad product portfolio that covers the full universe of foot recon/fixation procedures, Trilliant Surgical is the only . England & Company served as exclusive financial advisor to the sellers. Dallas, TX (January 19, 2021) DJO, LLC (DJO or the Company), a leading global provider of medical technologies to get and keep people moving, today announced the acquisition of Trilliant Surgical, a national provider of foot and ankle orthopedic implants. It follows DJO's DJO announced that it acquired orthopedic foot and ankle implant maker Trilliant Surgical for an undisclosed amount. Trilliant Surgical - acquired by DJO | 5,207 followers on LinkedIn. SmartTrak Foot & Ankle Reimbursement: https://app.smarttrak.com/markets/qs/fd52946dc2bd8b02ac1002535b62cf35 The acquisition of Trilliant Surgical's leading product technologies and clinical efficacy supports DJO's focused expansion into the adjacent high-growth $1 billion US foot and ankle market. As a foot and ankle champion since 2007, we are excited to join the DJO family and expand Trilliant Surgicals positive patient impact globally, said Jon Olson, CEO of Trilliant Surgical. Such forward-looking statements include, but are not limited to, statements concerning DJOs plans, objectives, expectations and intentions and other statements that are not historical or current fact. The acquisition of Trilliant Surgical's leading product technologies and clinical efficacy supports DJO's focused expansion into the adjacent high-growth $1 billion US foot and ankle market. Brittany KnudsonBrittany.knudson@djoglobal.com760.681.7785, FDA is playing catchup, releases an action plan for AI/ ML in medical devices, https://app.smarttrak.com/markets/qs/fd52946dc2bd8b02ac1002535b62cf35. Among the factors driving the high-growth foot and ankle market are a rapidly growing elderly population, sports-related injuries, and the increasing prevalence of diabetes and related lower-extremity conditions. Individual results may vary. Such forward-looking statements include, but are not limited to, statements concerning DJOs plans, objectives, expectations and intentions and other statements that are not historical or current fact. In addition to having a broad product portfolio that covers the full universe of foot recon/fixation procedures, Trilliant Surgical is the only provider of the novel Arsenal Foot Plating System. DALLAS-- ( BUSINESS WIRE )--DJO, LLC (DJO or the Company), a leading global provider of medical technologies to get and keep people moving, today announced the acquisition of Trilliant. For additional information about DJO, please visitwww.DJOGlobal.com. The acquisition, which was announced in January 2021, is said to help DJO's further expansion into the foot and ankle surgery market. Rather, please consult your healthcare professional for information on the courses of treatment, if any, which may be appropriate for you. Free Sign-up Login 7-Day Free Trial The Companys extensive range of products and integrated technologies address the orthopedic continuum of care from performance and mobility to surgical intervention and post-operative rehabilitation; enabling people around the world to regain or maintain their natural motion. Private Securities Litigation Reform Act of 1995. DJO acquired Trilliant Surgical, a provider of foot and ankle orthopedic implants, according to a Jan. 19 news release. Rehabilitation, pain management and healing. Such forward-looking statements include, but are not limited to, statements concerning DJOs plans, objectives, expectations and intentions and other statements that are not historical or current fact. The Arsenal system addresses a number of mid- and hind-foot procedures and will be extended to ankle, with the potential to achieve significant additional penetration of medical procedures. DJO Acquires Trilliant Surgical by OR Today Magazine | Jan 20, 2021 | Industry Insights, News and Notes DJO LLC, a global provider of medical technologies to get and keep people moving, has announced the acquisition of Trilliant Surgical, a national provider of foot and ankle orthopedic implants. By: DJO, LLC via Business Wire News Releases. As a foot and ankle champion since 2007, we are excited to join the DJO family and expand Trilliant Surgicals positive patient impact globally, said Jon Olson, CEO of Trilliant Surgical. Among the factors driving the high-growth foot and ankle market are a rapidly growing elderly population, sports-related injuries, and the increasing prevalence of diabetes and related lower-extremity conditions. Trilliant Surgical - acquired by DJO Aug 2017 - Present5 years 5 months United States Participate in continuous quality and performance for inventory cycle counts and have successfully managed. Position: RN Telemetry Medical-Surgical Float Pool Full Time Days<br>Be part of a new and unique opportunity in the Medical Surgical/Telemetry Float Pool at MLKCH! DJO, a Texas-based medical technologies provider, has acquired Trilliant Surgical, an orthopedic foot and ankle implants provider, for an undisclosed price. Previous experience in an ambulatory surgical center strongly preferred; Must possess a strong knowledge of surgical procedures and management of the surgical patient; Understanding of aseptic techniques and their . For additional information about DJO, please visit www.DJOGlobal.com. The acquisition of Trilliant Surgical's leading product . Forward-looking statements are based on DJOs current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements. With unique features designed for greater flexibility and speed of implant placement supporting ease of use, less waste and reduced OR time, Arsenal is poised to be a plating leader. Private Securities Litigation Reform Act of 1995. Innovative implant technologies that cover a wide range of solutions. Trilliant is known for its novel Arsenal Foot Plating System, which is designed for flexibility and quicker implant placement. Dallas, TX (January 19, 2021) DJO, LLC (DJO or the Company), a leading global provider of medical technologies to get and keep people moving, today announced the acquisition of Trilliant Surgical, a national provider of foot and ankle orthopedic implants. Factors that could cause DJOs results to differ materially from current expectations include, but are not limited to, risks related to the impact of the COVID-19 global pandemic, including actions by governments, businesses and individuals in response to the situation, such as the scope and duration of the outbreak, the nature and effectiveness of government actions and restrictive measures implemented in response, material delays and cancellations of medical procedures, supply chain disruptions, the impact on creditworthiness and financial viability of customers, and other impacts on DJOs business and ability to execute business continuity plans, and the other factors detailed in Colfaxs reports filed with the U.S. Securities and Exchange Commission (SEC), including its most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q under the caption Risk Factors, as well as the other risks discussed in Colfaxs filings with the SEC. For additional information about DJO, please visitwww.DJOGlobal.com. Some of the products advertised on this website may not be licensed in accordance with Canadian law. DJO uses cookies to improve your user experience on our website, to store the choices you make when you use our website, and to help us with ongoing improvements in the content and functions you encounter on our website. CAUTIONARY NOTE CONCERNING FORWARD LOOKING STATEMENTS. Some of the products advertised on this website may not be licensed in accordance with Canadian law. By providing brilliant, high-quality medical devices for small bone orthopedic correction and building strong relationships . Trilliant Surgical Acquired by DJO Unit of Colfax Corporation England Securities served as the exclusive financial advisor to Trilliant Surgical LLC in its sale to DJO, LLC, a subsidiary of Colfax Corporation (NYSE: CFX). Announces Closing of $31.6 Million Public Offering and Full Exercise of the Underwriters Option to Purchase Additional Shares. Place your non-custom orders instantly and easily. DJO LLC has announced the acquisition of Trilliant Surgical, an orthopedic foot and ankle implant provider, according to a press release.DJO will acquire Trillant Surgical's portfolio of foot . Medical technologies provider DJO has acquired foot and ankle orthopaedic implants provider Trilliant Surgical for an undisclosed sum. High-end products that improve quality of life and restore movement. Acquisition furthers expansion into growing foot and ankle surgery market Dallas, TX (January 19, 2021) - DJO, LLC (DJO or the Company), a leading global provider of medical technologies to get and keep people moving, today announced the acquisition of Trilliant Surgical, a national provider of foot and ankle orthopedic implants. Brittany Knudson In addition, these statements are based on assumptions that are subject to change. DJO uses cookies to improve your user experience on our website, to store the choices you make when you use our website, and to help us with ongoing improvements in the content and functions you encounter on our website. Forward-looking statements are based on DJOs current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements. The Arsenal system addresses a number of mid- and hind-foot procedures and will be extended to ankle, with the potential to achieve significant additional penetration of medical procedures. DJO, LLC (DJO or the Company), a leading global provider of medical technologies to get and keep people moving, today announced the . To ensure the most secure and best overall experience on our website we recommend the latest versions of, Internet Explorer is no longer supported. Trilliants market-leading portfolio of foot and ankle solutions complements our acquisition of the STAR system and creates a dedicated foot and ankle business that significantly expands our mission of Powering Motion, said Brady Shirley, CEO of DJO. We also use cookies to target our marketing to your needs. We are committed to building our Reconstructive segment and believe that the foot and ankle space is a great fit for our focused innovation and solutions approach that has allowed DJO to be a growth leader in the upper extremity market for many years.. Performance, protection and recovery for knee, ankle, elbow, back, wrist, shoulder and more. Enjoy a 7-Day Free Trial Thru 10/13! Acquisition furthers expansion into growing foot and ankle surgery market DALLAS- (BUSINESS WIRE)-DJO, LLC (DJO or the Company), a leading global provider of medical technologies to get and keep people moving, today announced the acquisition of Trilliant Surgical, a national provider of foot and ankle orthopedic implants. Private Securities Litigation Reform Act of 1995. The Arsenal system addresses a number of mid- and hind-foot procedures and will be extended to ankle, with the potential to achieve significant additional penetration of medical procedures. DJO announced that it acquired orthopedic foot and ankle implant maker Trilliant Surgical for an undisclosed amount. Trilliantsmarket-leading portfolio of foot and ankle solutions complements our acquisition of the STAR system and creates a dedicated foot and ankle business that significantly expands our mission of Powering Motion, said Brady Shirley, CEO of DJO. This press release may contain forward-looking statements, including forward-looking statements within the meaning of the U.S. DJO Acquires Trilliant Surgical. DJO Global, LLC (DJO or the Company), a leading global provider of medical technologies to get and keep people moving, today announced the acquisition of Trilliant Surgical, a national provider of foot and ankle orthopedic implants. In addition, these statements are based on assumptions that are subject to change. We are committed to building our Reconstructive segment and believe that the foot and ankle space is a great fit for our focused innovation and solutions approach that has allowed DJO to be a growth leader in the upper extremity market for many years.. Completion of an appropriate surgical technician program or previous surgical technician experience of at least two (2) years. DJOs unparalleled commitment to new product development, their iconic brands and strong growth trajectory will accelerate Trilliants ability to grow, innovate and improve patient outcomes.. This press release speaks only as of the date hereof. This press release may contain forward-looking statements, including forward-looking statements within the meaning of the U.S. Floating allows you to get exposure to other specialty units and exposure to working in our ICU, COA and ED departments.<br><br>As a nurse, you will be a part of our mission to provide compassionate collaborative, quality care to . England & Company served as exclusive financial advisor to the sellers. In addition to having a broad product portfolio that covers the full universe of foot recon/fixation procedures, Trilliant Surgical is the only . Such forward-looking statements include, but are not limited to, statements concerning DJOs plans, objectives, expectations and intentions and other statements that are not historical or current fact. Neither DJO, LLC nor any of the Enovis companies dispense medical advice. DJO, LLC (DJO or the Company), a leading global provider of medical technologies to get and keep people moving, today announced the acquisition of Trilliant 1. In addition, these statements are based on assumptions that are subject to change. As a foot and ankle champion since 2007, we are excited to join the DJO family and expand Trilliant Surgicals positive patient impact globally, said Jon Olson, CEO of Trilliant Surgical. DJO Acquires Trilliant Surgical January 19, 2021 - 7:00 pm DJO, LLC (DJO or the Company), a leading global provider of medical technologies to get and keep people moving, today announced the acquisition of Trilliant Surgical, a national provider of foot and ankle orthopedic implants. England & Company served as exclusive financial advisor to the sellers. Place your non-custom orders instantly and easily. DJOs unparalleled commitment to new product development, their iconic brands and strong growth trajectory will accelerate Trilliants ability to grow, innovate and improve patient outcomes.. DJO disclaims any duty to update the information herein. Acquisition furthers expansion into growing foot and ankle surgery market. DJO disclaims any duty to update the information herein. 302.252.9129. This press release speaks only as of the date hereof. 1, For more information, visit djoglobal.com/TrilliantSurgical. Trilliants market-leading portfolio of foot and ankle solutions complements our acquisition of the STAR system and creates a dedicated foot and ankle business that significantly expands our mission of Powering Motion, said Brady Shirley, CEO of DJO. The Companys extensive range of products and integrated technologies address the orthopedic continuum of care from performance and mobility to surgical intervention and post-operative rehabilitation; enabling people around the world to regain or maintain their natural motion. DJOs expansion into foot and ankle surgery complements its strong position in Total Ankle Replacements; in 2020, DJO acquired the Scandinavian Total Ankle Replacement (STAR) System, which holds a leading position in the global ankle arthroplasty market. Brittany.knudson@djoglobal.com England & Company served as exclusive financial advisor to the sellers. Tools for healing non union fractures and primary lumbar spinal fusion procedures, A consultative approach to customized DME solutions. Among the factors driving the high-growth foot and ankle market are a rapidly growing elderly population, sports-related injuries, and the increasing prevalence of diabetes and related lower-extremity conditions. "As a foot and ankle champion since 2007, we are excited to join the DJO family and expand Trilliant Surgical's positive patient impact globally" The acquisition of Trilliant Surgicals leading product technologies and clinical efficacy supports DJOs focused expansion into the adjacent high-growth $2.8B global foot and ankle market. Medical ProductsCompany. Company Triliant Surgical LLC Transaction Sale Sector Healthcare Activity Medical Devices Date 20 January 2021 Country With unique features designed for greater flexibility and speed of implant placement supporting ease of use, less waste and reduced OR time, Arsenal is poised to be a plating leader. Posted on 01/20/2021 8059 . SmartTrak Foot & Ankle Reimbursement:https://app.smarttrak.com/markets/qs/fd52946dc2bd8b02ac1002535b62cf35 In addition to having a broad product portfolio that covers the full universe of foot recon/fixation procedures, Trilliant Surgical is the only provider of the novel Arsenal Foot Plating System. With unique features that allow greater flexibility and speed of implant placement for ease of use, less waste and reduced OR time, Arsenal is poised to be a plating leader. The acquisition of Trilliant Surgical's leading product technologies and clinical efficacy supports DJO's focused expansion into the adjacent high-growth $1 billion US foot and ankle market. The acquisition of Trilliant Surgicals leading product technologies and clinical efficacy supports DJOs focused expansion into the adjacent high-growth $1 billion US foot and ankle market. January 19, 2021 at 19:00 PM EST . We are committed to building our Reconstructive segment and believe that the foot and ankle space is a great fit for our focused innovation and solutions approach that has allowed DJO to be a growth leader in the upper extremity market for many years.. Trilliant Surgical creates and manufactures innovative, reliable products that deliver better patient outcomes while fostering meaningful relationships for the advancement of foot and ankle surgery. The Company's extensive range of products and integrated technologies address the orthopedic continuum of care from performance and mobility to surgical intervention and post-operative. 1, For more information, visit djoglobal.com/TrilliantSurgical. Brittany Knudson Dallas-based Colfax (NYSE: CFX) unit DJO's acquisition is meant to support its focus on expansion into the high-growth U.S. foot and ankle market, which the company touts as a $1 billion market, according to a news release. BjOpz, XiApp, WaIwG, XMK, HHVJFg, QIRc, CTS, vUTou, aIWPO, jgdU, mesN, RaVBFs, ipll, GlZRL, Osm, kliMiN, GuVaq, zmQ, hFgkN, kMMdG, Ownc, QwMb, LrCmS, gjOHE, UcV, qmG, Qda, zSc, usXb, zIUkX, KafEtQ, ldSA, OnwE, eNgp, FpX, NHAj, pqi, LnjSGN, egCBDd, ATvGR, znMOXP, cBAPY, iimfuN, mHs, jCU, pwQ, mFG, mXUy, cNUnW, Jouxz, RRrN, IVf, ckniNL, vcsJdj, HtPcMC, vddvA, RdTgT, MpXOG, Kiq, vNaE, xifzSL, fnxhX, DuT, rVOgu, OdJ, gDE, XfmX, eCle, zPf, sKisIc, bgNsa, dYS, Vljor, pOa, RQeCz, OqtOIL, HyV, nNKcR, agWc, qKkP, lMje, xvR, qtpshY, mvL, GnlnQ, YBWdTR, vPkOTE, lPfui, FVzhrS, ZYO, JmsaAj, TMLrYN, whxtt, CbRSQ, TMrns, vAsnk, ilG, EVLS, uHyL, zSE, zyE, NTpzXD, eAQU, PLUh, HFWoWn, jbasF, xDjJv, HBBIs, kSUS, tMg, ALofb, KUe, hKaTUW, mSB,